Facebook Twitter instagram Youtube
dr-manas-kumar-sahoo

Dr. Manas Kumar Sahoo

Associate Director

Radiology & Imaging

MD(NUCLEAR MEDICINE) , MBBS

About Dr. Manas Kumar Sahoo

Introduced TRODAT SPECT in Medanta for movement disorder patients.
Introduced radioiodine Uptake (RAIU) study in Medanta for management of thyrotoxic patients.
Introduced low dose radioiodine therapy in Medanta for management of thyrotoxic patients.

Specialization and Expertise

Thyroid disease (hyperthyroid conditions like Graves’ disease, AFTN and thyroid cancer) management with radioiodine. Thyroid disease (hyperthyroid conditions like Graves’ disease, AFTN and thyroid cancer) management with radioiodine. Thyroid disease (hyperthyroid conditions like Graves’ disease, AFTN and thyroid cancer) management with radioiodine.
 Molecular Imaging including SPECT & PET  Molecular Imaging including SPECT & PET Molecular Imaging including SPECT & PET
 Nuclear medicine therapy for neuroendocrine tumor, prostate cancer with 177 Lu-DOTATATE & 177 Lu-PSMA  Nuclear medicine therapy for neuroendocrine tumor, prostate cancer with 177 Lu-DOTATATE & 177 Lu-PSMA Nuclear medicine therapy for neuroendocrine tumor, prostate cancer with 177 Lu-DOTATATE & 177 Lu-PSMA
 Pain palliation with nuclear medicine  Pain palliation with nuclear medicine Pain palliation with nuclear medicine

Milestones Achieved

Gold Medal in Medicine from Sambalpur University, Odisha, India
2011
Gold medal for BEST PAPER in Thyroidology by Society of NuclearMedicine, India 2011.
2012
AIOS Narshinga Rao Award for the BEST PAPER of UVEA Session, 70th AIOC Proceedings, 2012 by All India Opthalmological Society.
Back to top